ES2135811T3 - Indenoil-guanidinas sustituidas antiarritmicas y cardioprotectoras. - Google Patents

Indenoil-guanidinas sustituidas antiarritmicas y cardioprotectoras.

Info

Publication number
ES2135811T3
ES2135811T3 ES96105873T ES96105873T ES2135811T3 ES 2135811 T3 ES2135811 T3 ES 2135811T3 ES 96105873 T ES96105873 T ES 96105873T ES 96105873 T ES96105873 T ES 96105873T ES 2135811 T3 ES2135811 T3 ES 2135811T3
Authority
ES
Spain
Prior art keywords
indenoil
guanidinas
cardioprotector
antiarrhythmic
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96105873T
Other languages
English (en)
Inventor
Nirogi Ramakrishna
Tulsidas Sitaram More
Anagha Suhas Kulkarni
Bansi Lal
Roa Vadlamudi
Anil Vatantrao Ghate
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2135811T3 publication Critical patent/ES2135811T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Optical Record Carriers And Manufacture Thereof (AREA)

Abstract

SE DESCRIBEN INDENOILGUANIDINAS DE FORMULA I, EL PROCEDIMIENTO PARA SU PREPARACION, SU USO COMO MEDICAMENTOS, MEDICAMENTOS QUE LAS CONTIENEN, SU USO COMO AGENTES DE DIAGNOSTICO Y MEDICAMENTOS QUE CONTIENEN LOS MISMOS. COMPUESTOS I SON UTILES PARA EL TRATAMIENTO DE ARRITMIAS CARDIACAS. ADEMAS SON UTILES COMO AGENTES CARDIOPROTECTOTES EN MAMIFEROS, QUE COMPRENDE LA ADMINISTRACION DEL COMPUESTO DE FORMULA I CON LAS PROPIEDADES ARRIBA DESCRITAS EN COMBINACION CON UN TRANSPORTADOR FARMACEUTICAMENTE ACEPTADO PARA DICHO MAMIFERO.
ES96105873T 1995-04-18 1996-04-15 Indenoil-guanidinas sustituidas antiarritmicas y cardioprotectoras. Expired - Lifetime ES2135811T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95105724 1995-04-18
US08/633,223 US5733934A (en) 1995-04-18 1996-04-16 Antiarrythmic and cardioprotective substituted indenoylguanidines

Publications (1)

Publication Number Publication Date
ES2135811T3 true ES2135811T3 (es) 1999-11-01

Family

ID=26138562

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96105873T Expired - Lifetime ES2135811T3 (es) 1995-04-18 1996-04-15 Indenoil-guanidinas sustituidas antiarritmicas y cardioprotectoras.

Country Status (23)

Country Link
US (1) US5733934A (es)
EP (1) EP0738712B1 (es)
JP (1) JPH08291131A (es)
CN (1) CN1061648C (es)
AT (1) ATE183498T1 (es)
AU (1) AU706055B2 (es)
BR (1) BR9601989A (es)
CA (1) CA2174406A1 (es)
CZ (1) CZ291538B6 (es)
DE (1) DE69603771T2 (es)
DK (1) DK0738712T3 (es)
ES (1) ES2135811T3 (es)
GR (1) GR3031540T3 (es)
HU (1) HUP9600998A3 (es)
IL (1) IL117927A (es)
NO (1) NO305655B1 (es)
NZ (1) NZ286380A (es)
PL (1) PL182566B1 (es)
RU (1) RU2182902C2 (es)
SI (1) SI0738712T1 (es)
SK (1) SK282011B6 (es)
TR (1) TR199600316A1 (es)
ZA (1) ZA963046B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002502414A (ja) * 1997-06-02 2002-01-22 藤沢薬品工業株式会社 細胞中のＮａ▲上＋▼／Ｈ▲上＋▼交換の阻害剤としてのグアニジン誘導体
US6160134A (en) * 1997-12-24 2000-12-12 Bristol-Myers Squibb Co. Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
US6011059A (en) * 1997-12-24 2000-01-04 Bristol-Myers Squibb Company Acyl guanidine sodium/proton exchange inhibitors and method
TW462964B (en) * 1998-05-26 2001-11-11 Sumitomo Pharma Guanidine derivatives for the treatment and prevention of disorders caused by inhibiting hyperactivity of Na/H exchange transport system and process for producing the same
DE19859727A1 (de) 1998-12-23 2000-06-29 Aventis Pharma Gmbh Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verhinderung von altersbedingten Organ-Dysfunktionen, altersbedingten Erkrankungen zur Lebensverlängerung
JP2002542291A (ja) 1999-04-23 2002-12-10 ブリストル−マイヤーズ スクイブ カンパニー ジ環式アシルグアニジン・ナトリウム／プロトン交換抑制剤および方法
EP2617709B8 (en) * 2003-06-26 2022-12-21 Biotron Limited Guanidine derivatives as antiviral agents
US20070099968A1 (en) * 2004-06-26 2007-05-03 Biotron Limited Antiviral compounds and methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2734904A (en) * 1956-02-14 Xcxnhxc-nh
US3780027A (en) * 1970-04-29 1973-12-18 Merck & Co Inc Anthranilic acid derivatives
US4544670A (en) * 1982-08-24 1985-10-01 William H. Rorer, Inc. Method of treating coccidiosis with acyl guanidines
EP0556673B1 (de) * 1992-02-15 1997-09-17 Hoechst Aktiengesellschaft Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4326005A1 (de) * 1993-08-03 1995-02-09 Hoechst Ag Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament
EP0639573A1 (de) * 1993-08-03 1995-02-22 Hoechst Aktiengesellschaft Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
MX9601424A (es) 1997-07-31
CA2174406A1 (en) 1996-10-19
HUP9600998A2 (en) 1997-01-28
ZA963046B (en) 1996-10-22
HU9600998D0 (en) 1996-06-28
GR3031540T3 (en) 2000-01-31
BR9601989A (pt) 1998-04-07
CZ291538B6 (cs) 2003-03-12
IL117927A (en) 2001-12-23
SK48396A3 (en) 1996-12-04
HUP9600998A3 (en) 1997-11-28
AU5067696A (en) 1996-10-31
DE69603771D1 (de) 1999-09-23
CZ109696A3 (en) 1996-11-13
IL117927A0 (en) 1996-08-04
TR199600316A1 (tr) 1997-03-21
NO961521D0 (no) 1996-04-17
SI0738712T1 (en) 1999-12-31
NZ286380A (en) 1997-09-22
PL182566B1 (pl) 2002-01-31
CN1061648C (zh) 2001-02-07
AU706055B2 (en) 1999-06-10
EP0738712A1 (en) 1996-10-23
CN1140164A (zh) 1997-01-15
DE69603771T2 (de) 2000-09-07
SK282011B6 (sk) 2001-10-08
RU2182902C2 (ru) 2002-05-27
ATE183498T1 (de) 1999-09-15
NO305655B1 (no) 1999-07-05
NO961521L (no) 1996-10-21
US5733934A (en) 1998-03-31
DK0738712T3 (da) 2000-03-06
JPH08291131A (ja) 1996-11-05
EP0738712B1 (en) 1999-08-18

Similar Documents

Publication Publication Date Title
ES2093694T3 (es) Nuevos derivados de dihidro-isoquinoleina.
ES2154674T3 (es) Derivados de 1,5-benzodiacepinas con actividad antagonista o agonista de cck.
ES2150113T3 (es) Derivados de pirazol y procedimientos para la preparacion de los mismos.
ES2072323T3 (es) Compuestos de piperidina y su preparacion y empleo.
ES2165505T3 (es) Compuestos aromaticos y composiciones farmaceuticas que los contienen.
ES2154262T3 (es) Uso de compuestos macrolidos para enfermedades oculares.
GT199900070A (es) Derivados de isotiazol, utiles como agentes anticancerosos.
ES2170141T3 (es) 4-aminoderivados del acido micofenolico con actividad inmunosupresora.
AR003427A1 (es) Péptidos relacionados con dolastatina, procedimiento para prepararlos, composiciones farmacéuticas que los contienen y el uso de los mismos para la preparación de dichas composiciones farmacéuticas.
ES2143122T3 (es) Sulfonimidamidas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.
AR004545A1 (es) Derivados de purin-6-ona, procedimientos para su preparacion, el uso de los mismos en la preparacion de medicamentos, medicamentos que los contieneny un procedimiento para preparar dichos medicamentos
ES2084339T3 (es) Tetrahidropiridinas e hidroxipiperidinas sustituidas utiles como agentes para el sistema nervioso central.
ES2167544T3 (es) Dioxidos de benzotiazina como antagonistas de la endotelina.
ES2135811T3 (es) Indenoil-guanidinas sustituidas antiarritmicas y cardioprotectoras.
AR018162A1 (es) Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica
AR004474A1 (es) Compuestos de 10-aminoalifatil-dibenz [b,f]oxepinas antineurodegenerativamente activas, utiles para el tratamiento de estados neurodegenerativos y composiciones farmaceuticas que los contienen
ES2154002T3 (es) 2-naftoilguanidinas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.
ES2127263T3 (es) Nuevos trien-derivados cromenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2144154T3 (es) Derivados de eritromicina a 9-0-oxima dotados de actividad antibiotica.
ES2086195T3 (es) Nuevos derivados pseudopeptidicos de actividad antagonista de la bradiquinina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
AR004481A1 (es) Indenoilguanidinas sustituidas antiarritmicas y cardioprotectoras
ES2124267T3 (es) Derivados macrolidas de 16 eslabones con una actividad antibacteriana prolongada en el plasma, intermediarios de sintesis y procedimiento de preparacion.
AR008616A1 (es) Uso de derivados de fluo-antraciclinona y fluo-antraciclina.
ES2055440T3 (es) Derivados del acido quinurenico, su preparacion y composiciones farmaceuticas que los contienen.
ES2158383T3 (es) Guanididas de acidos tiofenil-alquenil-carboxilicos sustituidos, procedimiento para su preparacion, su utilizacion como medicamento o agente diagnostico, asi como medicamento que las contiene.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 738712

Country of ref document: ES